Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease
Part of paid clinical trials in Andover, Massachusetts.
- Sponsor
- Andover Research Eye Institute
- Study ID
- NCT07676084
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Dry Eye Disease (DED)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Preservative Free Polyethylene glycol 400 0.25% — DRUG4 times daily \[QID\]
- Propylene Glycol (0.6%) — DRUGPreservative Free Propylene Glycol (0.6%)
- Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5% — DRUGQID Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%
Study Details
A study to evaluate the effect of over- the- counter (OTC) lubricating eye drops on tolerability, symptoms and visual outcomes in patients with dry eye disease (DED)
Key Dates
- Start date
- Jun 3, 2026
- Status verified
- Jun 2026
- Primary completion
- Oct 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Blink® Triple Care Preservative-Free Lubricating Eye Drops (4 times daily [QID])
- Active Comparator: Blink® Triple Care Preservative-Free Lubricating Eye Drops (2 times daily [BID])
- Active Comparator: Propylene Glycol (0.6%)Systane® PRO Preservative-Free Lubricating Eye Drops (QID)
- Active Comparator: Refresh Optive Mega-3® Preservative-Free Lubricating Eye Drops (QID)
- Active Comparator: Systane® Original Preservative-Free Lubricating Eye Drops (QID)
Primary Outcome Measure
Ocular Surface Disease Index (OSDI) [ Time Frame: 14 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Andover Eye Associates | Andover | Massachusetts | 01810 |
Find similar trials in Andover, MA
By research site
Related Studies
- The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier FunctionPHASE4 · Recruiting · Southern California College of Optometry at Marshall B. Ketchum University · Fullerton, California
- Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract SurgeryRecruiting · Vance Thompson Vision · Sioux Falls, South Dakota
- SYSTANE® PRO vs. MIEBO™ in Dry Eye DiseasePHASE4 · Recruiting · Indiana University · Newport Beach, California
- Moderate-to-Severe Dry Eye Disease Relief Using AcoltremonEnrolling By Invitation · Colvard Kandavel Eye Center · Encino, California